OA11213A - Cox-2 selective carprofen for treating pain and inflammation in dogs - Google Patents

Cox-2 selective carprofen for treating pain and inflammation in dogs Download PDF

Info

Publication number
OA11213A
OA11213A OA9900242A OA9900242A OA11213A OA 11213 A OA11213 A OA 11213A OA 9900242 A OA9900242 A OA 9900242A OA 9900242 A OA9900242 A OA 9900242A OA 11213 A OA11213 A OA 11213A
Authority
OA
OAPI
Prior art keywords
cox
carprofen
inhibitors
inhibitor
inhibition
Prior art date
Application number
OA9900242A
Other languages
English (en)
Inventor
Kristin Marie Lundy
Anthony Paul Ricketts
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of OA11213A publication Critical patent/OA11213A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
OA9900242A 1997-05-05 1999-11-02 Cox-2 selective carprofen for treating pain and inflammation in dogs OA11213A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05

Publications (1)

Publication Number Publication Date
OA11213A true OA11213A (en) 2003-07-14

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9900242A OA11213A (en) 1997-05-05 1999-11-02 Cox-2 selective carprofen for treating pain and inflammation in dogs

Country Status (32)

Country Link
EP (1) EP0988034A1 (es)
JP (1) JP2000513020A (es)
KR (2) KR20010012300A (es)
CN (1) CN1255059A (es)
AP (1) AP9801234A0 (es)
AR (2) AR011726A1 (es)
AU (1) AU6932198A (es)
BG (1) BG103852A (es)
BR (1) BR9808720A (es)
CA (1) CA2288759A1 (es)
DZ (1) DZ2479A1 (es)
EA (1) EA003696B1 (es)
GT (1) GT199800063A (es)
HR (1) HRP980244A2 (es)
HU (1) HUP0001286A3 (es)
ID (1) ID21311A (es)
IL (1) IL132570A0 (es)
IS (1) IS5220A (es)
MA (1) MA26491A1 (es)
NO (1) NO995389L (es)
NZ (1) NZ500183A (es)
OA (1) OA11213A (es)
PA (1) PA8450601A1 (es)
PE (1) PE72599A1 (es)
PL (1) PL337003A1 (es)
SK (1) SK148199A3 (es)
TN (1) TNSN98059A1 (es)
TW (1) TW590773B (es)
UY (1) UY24989A1 (es)
WO (1) WO1998050033A1 (es)
YU (1) YU55899A (es)
ZA (1) ZA983722B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
EP1123091A1 (en) * 1998-10-23 2001-08-16 Merck Frosst Canada & Co. Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
EP1637137A3 (en) * 1999-03-10 2006-07-05 G.D. Searle LLC Method and composition for administering a cyclooxygenase-2 inhibitor to animals
AU1592901A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
AU2001259974A1 (en) * 2000-05-15 2001-11-26 Merck Frosst Canada & Co Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
EA200802070A1 (ru) 2000-06-13 2009-06-30 Вайет Болеутоляющее и противовоспалительные составы, содержащие ингибиторы циклооксигеназы-2
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
WO2002012549A1 (en) 2000-08-07 2002-02-14 Vanderbilt University Compositions and methods for detecting and quantifying cox-2 activity and 2-arachidonylglycerol metabolites
AU2002354901A1 (en) * 2001-07-16 2003-03-03 Edward Hogestatt Compounds with analgesic, antipyretic and/or anti-inflammatory activity
ATE342722T1 (de) 2003-05-07 2006-11-15 Osteologix As Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen
KR100780983B1 (ko) * 2003-07-31 2007-11-30 파마시아 앤드 업존 캄파니 엘엘씨 소염제의 분산성 제제
EP1940380A2 (en) * 2005-05-20 2008-07-09 Pfizer Limited Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-2 delta-ligands
US9114071B2 (en) 2007-04-04 2015-08-25 Sigmoid Pharma Limited Oral pharmaceutical composition
JP2010527285A (ja) 2007-04-26 2010-08-12 シグモイド・ファーマ・リミテッド 複数のミニカプセルの製造
ES2649112T3 (es) 2009-05-18 2018-01-10 Sigmoid Pharma Limited Composición que comprende gotas de aceite
WO2011018504A2 (en) 2009-08-12 2011-02-17 Sigmoid Pharma Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
WO2015134792A1 (en) 2014-03-06 2015-09-11 Aratana Therapeutics, Inc. Compositions of grapiprant and methods for using the same
BR112017009510A2 (pt) 2014-11-07 2017-12-19 Sigmoid Pharma Ltd composições compreendendo ciclosporina
CN107106536A (zh) * 2015-01-09 2017-08-29 美洲豹动物健康公司 治疗伴侣动物的腹泻的方法
US20230174485A1 (en) * 2020-03-25 2023-06-08 Sri International Lipoxygenase inhibitors
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions

Also Published As

Publication number Publication date
AR039628A2 (es) 2005-03-02
PL337003A1 (en) 2000-07-31
CN1255059A (zh) 2000-05-31
HRP980244A2 (en) 1999-02-28
DZ2479A1 (fr) 2003-02-01
NZ500183A (en) 2002-04-26
KR20010012300A (ko) 2001-02-15
MA26491A1 (fr) 2004-12-20
BG103852A (en) 2000-06-30
CA2288759A1 (en) 1998-11-12
NO995389L (no) 2000-01-04
GT199800063A (es) 1999-10-26
EA199900895A1 (ru) 2000-06-26
HUP0001286A2 (hu) 2000-11-28
BR9808720A (pt) 2000-07-11
ID21311A (id) 1999-05-20
SK148199A3 (en) 2001-09-11
IS5220A (is) 1999-10-19
WO1998050033A1 (en) 1998-11-12
YU55899A (sh) 2003-08-29
TNSN98059A1 (fr) 2005-03-15
AR011726A1 (es) 2000-08-30
KR20040004406A (ko) 2004-01-13
ZA983722B (en) 1999-11-04
EA003696B1 (ru) 2003-08-28
TW590773B (en) 2004-06-11
HUP0001286A3 (en) 2000-12-28
NO995389D0 (no) 1999-11-04
PE72599A1 (es) 1999-08-12
UY24989A1 (es) 2001-10-25
IL132570A0 (en) 2001-03-19
AU6932198A (en) 1998-11-27
PA8450601A1 (es) 2000-05-24
AP9801234A0 (en) 1999-11-04
JP2000513020A (ja) 2000-10-03
EP0988034A1 (en) 2000-03-29

Similar Documents

Publication Publication Date Title
OA11213A (en) Cox-2 selective carprofen for treating pain and inflammation in dogs
TWI268925B (en) 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them
US6399647B2 (en) Amide derivatives for antiangiogenic and/or antitumorigenic use
KR101890442B1 (ko) P2x4 수용체 길항제
BR112013000783B1 (pt) Derivados arilamídicos apresentando propriedades antiandrogênicas, seu processo de preparação, e composição farmacêutica
US6552077B2 (en) Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
JP2003530438A (ja) 化合物および方法
US6878733B1 (en) Formulations for pharmaceutical agents ionizable as free acids or free bases
TW201002311A (en) Novel compositions and methods for treating hyperproliferative diseases
US20030212123A1 (en) COX-2 selective carprofen for treating pain and inflammation in dogs
US20210347742A1 (en) Cftr regulators and methods of use thereof
JP2003502367A (ja) インドール化合物
HU230250B1 (hu) Piperazinilkarbonilkinolinok és -izokinolinok
AU773615B2 (en) COX-2 selective carprofen for treating pain and inflammation in dogs
NZ516914A (en) Compositions containing COX-2 selective carprofen and derivatives thereof for treating pain and inflammation in dogs
US9079876B2 (en) Imidazole derivatives and preparation method and use thereof
TW200826932A (en) Semi-solid formulations of phospholipase enzyme inhibitors
BRPI0610110A2 (pt) derivados de sal de 3,4-diidroisoquinolìnio
AU2003232788B2 (en) Annelated pyrrole compounds as proton pump inhibitors for treating ulcer
CZ9903896A3 (cs) Léčivo, farmaceutický přípravek a souprava pro léčení nebo prevenci bolesti a zánětlivých procesů
WO1999036068A1 (fr) Activateurs des canaux de potassium
JPH072737B2 (ja) 5−リポキシゲナ−ゼ経路の抑制
FR2565588A1 (fr) Produits pharmaceutiques cardio-actifs, en particulier anti-arythmiques, a base de composes triaminoarylpteridiniques
JP3987113B2 (ja) 抗高血圧活性を有する新規キナゾリン―4―アミノ―2―(ピペリジン―1―イル―4―置換)誘導体並びにその製造法および医薬用途
JPH0770083A (ja) イミダゾール誘導体を有効成分とする血圧降下剤